Homocysteine Study (HOST)
NCT00032435
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2003
Enrollment
FED
Sponsor class
Conditions
End Stage Renal Disease
Renal Failure
Interventions
DRUG:
PAL-40 Active
DRUG:
PAL-40 Placebo
Sponsor
US Department of Veterans Affairs
Collaborators
[object Object]
[object Object]